Skip to main content
Case Reports, Infections, Transplant, Pediatric Cancer
Isavuconazonium Sulfate Dosing in Pediatric Patients Using Serum Therapeutic Drug Monitoring at a Single Center: A Case Series
Ashley M. Martin, PharmD; Christine E. MacBrayne, PharmD, MSCS, BCIDP; Alyssa Heiden, PharmD; Jason Child, PharmD; Donna J. Curtis, MD, MPH; Andrew S. Haynes, MD
Read More
Case Reports, Sarcoma, Immunotherapy
Complete Pathologic Response to Pembrolizumab in a Patient with Cutaneous Angiosarcoma: Case Report
Michael J. Nathenson, MD, and Jason L. Hornick, MD, PhD
Read More
Original Research, Oncology Pharmacy Programs/Protocols, Oral Therapy
Time to First Palbociclib Prescription Dispense at Mayo Clinic: Comparing a Health-System Specialty Pharmacy with External Specialty Pharmacies
Allison P. Golbach, PharmD; Jodi L. Taraba, PharmD; Matthew D. Smith, PharmD; Kristin C. Mara, MS; Karthik V. Giridhar, MD
Read More
Clinical Trials, Melanoma
Pyrexia Management in Patients with Melanoma Treated with Dabrafenib/Trametinib Combination Therapy
Read More
Case Reports, Lung Cancer, Tyrosine Kinase Inhibitor
Third-Line Tyrosine Kinase Inhibitor Therapy Results in 16-Year Remission in a Patient with Stage IV Non–Small-Cell Lung Cancer
Carrie L. Barnhart, PharmD, BCOP, and David F. Christianson, MD
Read More
Practical Issues in Pharmacy Management
Sterility of Single-Use Vials When Using a Closed-System Transfer Device
Joan Antoni Schoenenberger-Arnaiz, PharmD, PhD; Maria Nevot-Blanc, PharmD; Merce Garcia-Gonzalez, PharmD; Mireia Martinez-Sogues, PharmD; Aida Moroba-Estor; Laura Rumi-Carrera, PharmD; Jason Battle, BS
Read More
FDA Updates
Xalkori Now FDA Approved for the Treatment of ALK-Positive Inflammatory Myofibroblastic Tumor
Read More
FDA Updates
Breyanzi Now FDA Approved for Second-Line Treatment of Large B-Cell Lymphoma
Read More
FDA Updates
Tafinlar plus Mekinist First Tumor Agnostic Therapy Approved for Any Unresectable or Metastatic Solid Tumors with BRAF Mutation
Read More
Meeting Highlights Online Only
ASCO Highlights
PD-1 Inhibition with Dostarlimab Led to Remission in All Patients with Mismatch Repair-Deficient Rectal Cancer
Read More
Page 47 of 196
Results 461 - 470 of 1953